Risultati ricerca pubblicazioni

Plasma Aβ42 as biomarker of prodromal Alzheimer's disease progression in patients with amnestic mild cognitive impairment: evidence from the pharmaCog/E-ADNI study

pubblicato su: JOURNAL OF ALZHEIMER'S DISEASE - 2018

Albani Diego, Marizzoni Moira, Ferrari Clarissa, Fusco Federica, Boeri Lucia, Raimondi Ilaria, Jovicich Jorge, Babiloni Claudio, Soricelli Andrea, Lizio Roberta, Galluzzi Samantha, Cavaliere Libera, Didic Mira, Schönknecht Peter, Molinuevo José Luis, Nobili Flavio, Parnetti Lucilla, Payoux Pierre, Bocchio Luisella, Salvatore Marco, Rossini Paolo Maria, Tsolaki Magda, Visser Pieter Jelle, Richardson Jill C, Wiltfang Jens, Bordet Régis, Blin Olivier, Forloni Gianluigi, Frisoni Giovanni B, Consortium Pharmacog

Ricerc@Sapienza

Risultati ricerca pubblicazioni

Plasma Aβ42 as biomarker of prodromal Alzheimer's disease progression in patients with amnestic mild cognitive impairment: evidence from the pharmaCog/E-ADNI study

Looking for a treatment for the early stage of Alzheimer’s disease: preclinical evidence with co-ultramicronized palmitoylethanolamide and luteolin